Results 211 to 220 of about 3,863,870 (310)

Primary care occupational therapist's methods of outcome evaluation: Do they align to value-based healthcare? [PDF]

Br J Occup Ther
Ingham L, Cooper A, Purcell C.
europepmc   +1 more source

A Comparative Evaluation of AFI Measurement Techniques and Their Association with Fetomaternal Outcomes in Late Pregnancy

Sheza Sajjad
openalex   +2 more sources

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

Molecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Epidemiological Data, Clinical Signs, Therapy and Outcome Evaluation in Dogs with Syringomyelia of Different Etiology. [PDF]

Vet Sci
Baka RD, Savvas I, Sarpekidou E, Kazakos G, Polizopoulou Z.   +4 more
europepmc   +1 more source

Evaluating Outcomes in Patients with Pancreatic Cancer Undergoing Chemotherapy with Adjuvant Sonoporation Treatment Using Subharmonic‐Aided Pressure Estimation ( SHAPE ) [PDF]

openalex   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

Molecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon, Dong Young Kim, Yuna Kim, Uk‐Il Kim, Jae‐Sung Kim   +4 more
wiley   +1 more source

Outcome evaluation for the treatment of low flow venous and lymphatic malformations. [PDF]

CVIR Endovasc
Moussa RM, Oseni AO, Patel S, Mailli L, Morgan R, Ratnam LA.   +5 more
europepmc   +1 more source

Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver

Molecular Oncology, EarlyView.
Meta‐transcriptome analysis identified FGF19 as a peptide enteroendocrine hormone associated with colorectal cancer prognosis. In vivo xenograft models showed release of FGF19 into the blood at levels that correlated with tumor volumes. Tumoral‐FGF19 altered murine liver metabolism through FGFR4, thereby reducing bile acid synthesis and increasing ...
Jordan M. Beardsley, Michael W. Rohr, Joseph A. Goode, Sai Preethi Nakkina, Jignesh G. Parikh, Deborah A. Altomare   +5 more
wiley   +1 more source

Reply to: "Does 'the different study period' influence outcome evaluation?" [PDF]

J Chin Med Assoc
Chang CH, Chang SC, Jiang JK, Wang HS, Lan YT, Lin CC, Lin HH, Huang SC, Cheng HH, Yang YW, Lin YZ.   +10 more
europepmc   +1 more source

Methodological Evaluation of Urban Primary Care Networks in Nigeria: A Difference-in-Differences Approach to Assess Clinical Outcomes

, 2005
Ifeyinfa Anyaoku, Chinedu Obiora, Chidi Chukwuneke, Obiageli Nwankwo   +3 more
openalex   +1 more source